Search

Your search keyword '"drug-induced parkinsonism"' showing total 420 results

Search Constraints

Start Over You searched for: Descriptor "drug-induced parkinsonism" Remove constraint Descriptor: "drug-induced parkinsonism"
420 results on '"drug-induced parkinsonism"'

Search Results

2. Chlorpromazine-Induced Parkinsonism: A Case Report.

3. White Matter Microstructure Alteration in Patients with Drug-Induced Parkinsonism: A Diffusion Tensor Imaging Study with Tract-Based Spatial Statistics

4. The effects that secondary parkinsonian syndromes have on health status.

5. From one to many: Hypertonia in schizophrenia spectrum psychosis an integrative review and adversarial collaboration report.

6. Paratonia, Gegenhalten and psychomotor hypertonia Back to the roots.

7. The effects that secondary parkinsonian syndromes have on health status

8. Effects of defoliant exposure and medication use on the development of Parkinson's disease in veterans.

9. Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic

10. Treatment Changes and Prognoses in Patients with Incident Drug-Induced Parkinsonism Using a Korean Nationwide Healthcare Claims Database.

11. Prolonged extrapyramidal symptoms induced by long‐term, intermittent administration of low‐dose olanzapine along with metoclopramide for emesis: A case report

12. Risk factors, clinical correlates, and social functions of Chinese schizophrenia patients with drug-induced parkinsonism: A cross-sectional analysis of a multicenter, observational, real-world, prospective cohort study.

14. Spatial discrimination in patients with MSA, PSP, DIP, and VP with pain.

15. Drug-induced parkinsonism: diagnosis and treatment.

16. White Matter Microstructure Alteration in Patients with Drug-Induced Parkinsonism: A Diffusion Tensor Imaging Study with Tract-Based Spatial Statistics.

17. Low-frequency EEG power and coherence differ between drug-induced parkinsonism and Parkinson's disease.

18. Candidate genes of the development of antipsychotic-induced parkinsonism in patients with schizophrenia

19. Drug-induced parkinsonism

20. Drugs associated with DIP

21. Prolonged extrapyramidal symptoms induced by long‐term, intermittent administration of low‐dose olanzapine along with metoclopramide for emesis: A case report.

22. Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism.

23. Treatment of antipsychotic-induced parkinsonism in schizophrenic patients

24. Lithium-induced parkinsonism associated with vocal cord paralysis: an atypical presentation.

25. Time to onset of drug-induced parkinsonism: Analysis using a large Japanese adverse event self-reporting database.

26. Use of antipsychotics and long-term risk of parkinsonism.

29. The use of pramipexole in drug-induced parkinsonism: A case study on a patient with bipolar depression

30. Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia.

31. Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents.

32. Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report

33. Electroconvulsive Therapy as a Corrector for Certain Side Effects of Antipsychotic Therapy

34. The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson’s disease

35. Sum of the parts: a cascade of adverse effects.

36. Outcome of Drug-Induced Parkinsonism in the Elderly: A Permanent Nonprogressive Parkinsonian Syndrome May Occur Following Discontinuation of Cinnarizine and Flunarizine.

37. Chronic Neuroleptic Therapy and Progressive Parkinsonism: A Case Report.

38. Diagnostic accuracy of brain stem auditory evoked response in distinguishing drug-induced parkinsonism from Parkinson'sdisease.

39. Parkinson’s Disease-Related Brain Metabolic Pattern Is Expressed in Schizophrenia Patients during Neuroleptic Drug-Induced Parkinsonism

40. Drug-induced parkinsonism: what should a psychiatrist know?

41. Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea

42. Reversible drug-induced progressive supranuclear palsy-like presentation: A report of three cases

43. Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism

44. Drug-Induced Movement Disorders

45. Disproportionality by sex in the prescription of drugs capable of inducing parkinsonism for the elderly: A survey using statistics of Japanese national health claims from 2014 to 2017.

46. Evaluation and Management of Tremor.

47. Risks of Sulpiride-Induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients in Taiwan: A Nationwide Population-Based Study

48. Respecting the Patient’s Choice: A Case of Possible Drug-Induced Parkinsonism

49. Using accelerometer as a diagnostic tool to detect drug-induced parkinsonism (DIP) secondary to first-generation anti-psychotic medications.

50. Impaired functional connectivity of sensorimotor network predicts recovery in drug-induced parkinsonism.

Catalog

Books, media, physical & digital resources